Related Experiment Video
Updated: Jun 3, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
[Diabetic cardiomyopathy]
Ya-Qian Huang1, Xian Wang, Wei Kong
1Department of Physiology and Pathophysiology, Peking University Health Science Center, Beijing 100191, China.
Insights
Diabetic cardiomyopathy involves heart muscle changes and scarring, driven by diabetes. Understanding its complex mechanisms, including metabolic issues and fibrosis, is key to defining diabetes-related heart diseases.
Area of Science:
- Cardiology
- Endocrinology
- Pathology
Abstract:
Diabetic cardiomyopathy is characterized by myocardial hypertrophy and fibrosis independent of hypertension, coronary artery disease or other idiopathic heart diseases. The underlying mechanisms of diabetic cardiomyopathy are still elusive. Previous studies have highlighted the importance of metabolic disturbances (dysfunction of glucose transporters, increased free fatty acids, abnormal changes in calcium homeostasis, disordered copper metabolism, insulin resistance), myocardial fibrosis (association with hyperglycemia, myocyte apoptosis, increases in angiotensin II , IGF-1, and pro-inflammatory cytokines, changes in matrix metalloproteinases activity etc.), cardiac autonomic neuropathy, and stem cell in the evolution of diabetic cardiomyopathy. The current overview will focus on the recent advance of pathogenesis of diabetic cardiomyopathy and may help to define the pathology of diabetes related heart diseases.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy VI: Nursing Management

